期刊文献+

巨噬细胞移动抑制因子在溃疡性结肠炎发病中的作用 被引量:2

Pathogenic role of macrophage migration inhibitory factor in ulcerative colitis
下载PDF
导出
摘要 目的探讨巨噬细胞移动抑制因子(MIF)在溃疡性结肠炎发病中的意义。方法检测38例活动期溃疡性结肠炎(UC,其中轻度10例,中度20例,重度8例)、23例其他结肠炎患者和20例健康体检者血清中MIF及超敏C反应蛋白(hs-CRP)含量及肠黏膜组织中MIF的表达情况。结果UC患者的血清MIF水平高于其他结肠炎及正常对照者的血清MIF水平(P<0.05);溃疡性结肠炎重度组的MIF水平高于轻度组[(12.204±2.340)μg/Lvs(9.060±1.444)μg/L,P<0.05]。溃疡性结肠炎重度组的hs-CRP水平高于轻度组[(9.002±1.538)μg/Lvs(3.556±1.283)μg/L,P<0.05]。UC患者肠黏膜的MIF表达率为100%、染色明显增强,与其他结肠炎患者及正常对照者比较均具有显著性差异(P<0.01)。结论MIF参与溃疡性结肠炎的发病过程,可能是溃疡性结肠炎活动的指标,控制MIF的产生可能有治疗作用。 Objective To explore the pathogenic role of macrophage migration inhibitory factor(MIF) in patients with ulcerative colitis (UC). Methods A total of 38 patients with UC at active stage,23 patients with other forms of colitis and 20 normal controls were enrolled in the study. The levels of MIF in the sera and intestine tissues were detected. Meanwhile, the levels of high sensitivity C-reactive protein(hs-CRP) in the serum were measured. Results The serum MIF levels were significantly higher in UC than in other forms of colitis and normal controls (P 〈0. 05 ). Moreover, serum hs-CRP level in the patients with severe UC was significantly higher than that in mild UC (P 〈0. 05 ). The expression rate of MIF in UC was 100% , and the staining was significantly increased in colonic mucosa in UC than in other forms colitis ( P 〈 0.01 ). Conclusion These results suggest that MIF may play a role in the pathogenesis of UC, and may be used as a marker of disease activity in UC. To inhibit MIF expression may be a way to treat UC.
出处 《山西医科大学学报》 CAS 2009年第6期526-528,576,共4页 Journal of Shanxi Medical University
基金 广西壮族自治区卫生厅科研基金资助项目(Z2005120)
关键词 超敏-C反应蛋白 巨噬细胞移动抑制因子 溃疡性结肠炎 high sensitivity C-reactive protein macrophage migration inhibitory factor ulcerative colitis
  • 相关文献

参考文献10

  • 1Fiocchi C. Inflammatory bowel disease:etiology and pathogenesis [ J ]. Gastroenterology, 1998,115 ( 1 ) : 182 - 205.
  • 2Calandra T, Bucala R. Macrophage migration inhibitory factor (MIF) :a glucocorticoid counter-regulator within the immune system[J]. Crit Rev Immunol, 1997,17( 1 ) :77 -88.
  • 3Ohkawara T, Miyashita K, Nishihira J, et al. Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis [ J ]. Clin Exp Immuno1,2005,140 (2) :241 - 248.
  • 4Murakami H, Akbar SM, Matsui H, et al. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis:clinical implications and pathogenic significance[ J]. Eur J Clin Invest,2001,31 (4) :337 - 343.
  • 5欧阳钦,潘国宗,温忠慧,万学红,胡仁伟,林三仁,胡品津.对炎症性肠病诊断治疗规范的建议[J].中华消化杂志,2001,21(4):236-239. 被引量:1123
  • 6Castella E, Ariza A, Femandez-Vasalo A, et al. Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma [ J ]. J Clin Pathol, 1996,49 ( 6 ) : 489 - 492.
  • 7Gambin R. C-reactive protein-undervalued, underutilized [ J ]. Clin Chem, 1997,43 ( 11 ) :2017 - 2018.
  • 8Dunker MS, Ten Hove T, Bemelman WA, et al. Interleukin-6, Creactive protein, and expression of human leukocyte antigen-DR on peripheral blood mononuclear ceils in patients after laparoscopic vs. conventional bowel resection : a randomized study [ J ]. Dis Colon Rectum ,2003,46 (9) : 1238 - 1244.
  • 9Cabrera-Abreu JC, Davies P, Matek Z,et al. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic[J]. Arch Dis Child,2004,89( 1 ) :69 -71.
  • 10Ohkawara T,Takeda H, Nishihira H, et al. Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice[ J ]. Clin Exp Immunol,2005,141 ( 3 ) :412 - 421.

共引文献1122

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部